Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial5

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial2

Views

Views
November 20230
December 20231
January 20241
February 20240
March 20240
April 20240
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
 

Top cities views

Views
Ashburn1
Boardman1